Transcript Prezentace aplikace PowerPoint

Poland
Total expenditures - % GDP in 2005
Mexico
Slovak Republic
Czech Republic
Ireland
Finland
Spain
Italy
Sweden
Norway
Denmark
Iceland
Canada
Portugal
Austria
Germany
0,0
5,0
10,0
%
15,0
20,0
France
Slovak Republic
Pharmaceutical expenditures - % total
Switzerland
Poland
United States
Czech Republic
Spain
Portugal
Mexico
Italy
Canada
France
Finland
Germany
Iceland
United States
Sweden
Austria
Ireland
source: http://www.oecd.org/dataoecd/46/36/38979632.xls
[12.10.2007]
0,0
10,0
20,0
%
30,0
40,0
Switzerland
Norway
Denmark
◘
In June 2003, legal amendments
dramatically changed the drug
categorization system. The number of ATC
groups in which at least one drug has to be
fully reimbursed by law decreased to 122.
◘
The composition of the categorization
committee was changed, with greater
participation of health insurance
companies΄ representatives and a higher
emphasis on cost-effectiveness analysis.
◘
Generic substitution, maximum prices,
price monitoring in the reference
countries are implemented within the
Slovak’s drug policy and introduction of a
degressive margin is prepared.
Problems:
The cost – effectiveness threshold is not agreed.
an example:
ATC group
Name
dosis
A02BC01
Omeprazol
Price
per day €
10 mg 0.52
A02BC01
Omeprazol
20 mg 0.12
A02BC02
Pantoprazol
20 mg 1.45
A02BC02
Pantoprazol
40 mg 1.27
A02BC05
Ezomeprazol 20 mg 0.86
A02BC05
Ezomeprazol 40 mg 0.75
433 %
1208 %
The majority of HTA are transfrered.
however
Not all participated parties within
reimbursement process determine 14
transferability factors:
◘ To which content it is relevant for the investigated
technology
◘ How much it corresponds between the study and
country’s decision
◘ The likely effect of the transferability factor on the
cost-effectiveness ratio
◘
Inconsistent reimbursement decisions
can be consider as one of the main reasons
for the accumulation of expenditures on
drugs within the Slovak Republic.
The principe “VALUE FOR MONEY”
as a reasonable criterion for making
resource allocation decision within the
health care system should be
implemented more deeply.
◘